Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 October 2020: Clinical Research

miR-106a Targets Anoctamin 1 (ANO1) to Regulate Lipopolysaccharide (LPS)-Induced Inflammatory Response in Macrophages

Junfeng Heng 1CDEF , Dingye Wu 2BCD , Shiqi Lu 1CDE* , Yiming Zhao 2ABCD

DOI: 10.12659/MSM.922479

Med Sci Monit 2020; 26:e922479

Figure 5 Overexpression of miR-106a attenuates anoctamin 1 (ANO1)-mediated inflammatory inhibition in lipopolysaccharide (LPS)-treated RAW264.7 cells. (A, B) Messenger ribonucleic acid (mRNA) and protein levels of ANO1 were measured in cells with transfection of pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic. (C, D) mRNA levels of interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) were measured in LPS-treated RAW264.7 cells transfected with pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic via quantitative real-time polymerase chain reaction. (E, F) Secretion levels of IL-6 and TNF-α were detected in cells transfected with pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic by enzyme-linked immunosorbent assay. * P<0.05.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750